D.E. Shaw & Co
SLGC

D.E. Shaw & Co’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

D.E. Shaw & Co’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56,883
Closed -$136K – 4709
2023
Q3 		$136K Sell
56,883
-56,365
-50% -$125K ﹤0.01% 3823
2023
Q2 		$262K Sell
113,248
-93,859
-45% -$265K ﹤0.01% 3647
2023
Q1 		$528K Sell
207,107
-184,334
-47% -$528K ﹤0.01% 3525
2022
Q4 		$983K Sell
391,441
-88,766
-18% -$248K ﹤0.01% 3463
2022
Q3 		$1.39M Buy
480,207
+173,022
+56% +$728K ﹤0.01% 3330
2022
Q2 		$1.39M Buy
307,185
+192,534
+168% +$1.15M ﹤0.01% 3391
2022
Q1 		$920K Sell
114,651
-165,375
-59% -$1.46M ﹤0.01% 3981
2021
Q4 		$3.26M Sell
280,026
-1,052,336
-79% -$12.6M ﹤0.01% 2859
2021
Q3 		$16.5M Buy
+1,332,362
New +$15M 0.01% 1147

Other funds holding SLGC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's SLGC Position: Q4 2023 in Review

D.E. Shaw & Co sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 56,883 shares — an estimated $136K sold.

D.E. Shaw & Co first reported a position in SLGC in Q3 2021 and held it in 9 quarters. The position peaked at $16.5M in Q3 2021. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • D.E. Shaw & Co reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 56,883 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $136K.
  • D.E. Shaw & Co first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 9 quarters.
  • D.E. Shaw & Co's SomaLogic, Inc. Class A Common Stock position peaked at $16.5M in Q3 2021.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.